Noom vs Found for Weight Loss: Behavioral App vs Multi-Medication Program
An independent, side-by-side comparison of Noom and Found for GLP-1 weight loss programs — pricing, medications, protocols, and patient experience.
Quick Verdict
Best Price
Found
Starting at $149/mo vs $199/mo
Most Medications
Noom
2 medications vs 2
Best for Beginners
Found
Video Telehealth, fast onboarding
Head-to-Head Comparison
Pricing Breakdown
Side-by-side pricing for every medication.
| Medication | Noom | Found | Savings |
|---|---|---|---|
| Semaglutide | $199/monthly | $149/monthly | Save $50/mo with Found |
| Tirzepatide | Not offered | $399/monthly | Only at Found |
Pros and Cons
Noom
- Unique combination of GLP-1 medication with an established CBT-based behavior-change curriculum
- Video consultations required (more thorough clinical evaluation than async providers)
- Over a decade of behavior-change coaching experience predating the medication program
- Personal coach and group coaching included in the price
- Competitive compounded semaglutide pricing ($149/month) for what's included
- Cannot opt out of the coaching/app component to lower cost
- Noom Med is relatively new (launched 2023)
- No published clinical trial data specifically for the combined Med + coaching program
- No lab testing included
- Pricing has been volatile
Found
- Holistic approach — medication + coaching + community
- Board-certified obesity medicine specialists
- Competitive compounded semaglutide pricing
- Personalized weight-loss plans with behavior change focus
- Slower shipping than competitors (5-7 days)
- No lab testing included
- Coaching quality can vary
- Limited to weight-loss medications only
How They Compare
Our editorial assessment across key dimensions.
In-Depth Comparison
By sarah-chen · Last updated April 15, 2026
Noom vs Found for Weight Loss (2026)
Noom and Found occupy different positions in the weight loss landscape. Noom is a behavioral psychology-based program — structured cognitive behavioral therapy (CBT) delivered through an app, with optional GLP-1 prescribing added as Noom Med. Found is a clinical weight management platform built around medication matching: GLP-1, non-GLP-1, and combination approaches based on a patient's metabolic profile.
Quick Comparison
| Noom | Found | |
|---|---|---|
| Core model | Behavioral/CBT app + optional medication | Clinical medication matching + coaching |
| Primary strength | Psychology-based behavior change | Multi-medication clinical matching |
| GLP-1 access | Yes — Noom Med add-on | Yes — primary offering |
| Non-GLP-1 options | Limited | Yes — naltrexone/bupropion, metformin, orlistat |
| Monthly cost (behavioral) | ~$60–70/month | ~$99/month |
| Monthly cost (with GLP-1) | ~$149–199+/month (med add-on) | ~$149–199/month (all-in) |
| Coaching model | Structured 1:1 CBT coach | Clinical team + lifestyle coach |
| Insurance navigation | Limited | Yes — insurance navigation support |
| App-first experience | Yes — app is central product | App + clinical program |
Noom's Model: Behavior Change First
Noom was built on the premise that sustainable weight loss requires changing eating psychology and habits — not just reducing calories. The program delivers:
- Daily lessons in cognitive behavioral therapy, habit formation, and food psychology
- Personalized daily calorie targets with food logging
- 1:1 human coach (asynchronous) with weekly check-ins
- Meal tracking, weigh-ins, step counts
Noom Med adds GLP-1 or other prescription medication as an adjunct to the behavioral program. Noom's philosophy treats medication as a tool that works best alongside the psychological program.
Noom strengths:
- Best-in-class behavioral curriculum among telehealth weight loss platforms
- Cost-effective for patients who want structured behavioral coaching without medication
- Medication + psychology integration is clinically sound (combination outperforms either alone)
Noom limitations:
- GLP-1 prescribing is an add-on, not the core design
- Limited multi-medication matching depth vs Found
- Primary care prescriber model — not obesity medicine specialists
Found's Model: Clinical Matching for the Right Medication
Found was designed to solve the "which medication for this patient" problem. The platform matches patients to the right pharmacotherapy based on metabolic profile, medical history, comorbidities, and preferences.
Found's medication options:
| Category | Medications |
|---|---|
| GLP-1 | Compounded semaglutide, compounded tirzepatide |
| Non-GLP-1 | Naltrexone/bupropion (Contrave), metformin |
| Combination | GLP-1 + naltrexone/bupropion in some patients |
Found strengths:
- Broadest medication matching of cash-pay telehealth platforms
- Non-GLP-1 options for patients with GI side effect issues or contraindications
- Insurance navigation support for patients with coverage potential
- Clinical program designed around medication management, not just behavioral coaching
Found limitations:
- Behavioral coaching depth below Noom's curriculum
- Medication-first approach may underemphasize habit formation
Cost Over 12 Months
| Scenario | Noom (behavioral only) | Noom (behavioral + GLP-1) | Found (all-in) |
|---|---|---|---|
| Annual program cost | ~$720–840 | ~$1,788–2,388 | ~$1,188–2,388 |
| GLP-1 medication cost (compounded) | N/A | Included | Included |
| Best for | Behavior-first patients | Behavior + medication integration | Clinical matching priority |
Who Should Use Each
Noom if you:
- Believe your weight challenges are primarily psychological/behavioral
- Have had success with caloric restriction but struggle with consistency
- Want the most structured behavioral program available in telehealth
- Are adding medication to an already solid behavioral foundation
- Are cost-sensitive and want behavioral coaching without medication
Found if you:
- Want clinical medication matching that goes beyond GLP-1
- Have tried GLP-1 with suboptimal response and want non-GLP-1 options evaluated
- Need insurance navigation for GLP-1 coverage
- Want a program centered on clinical medication management with coaching support
- Have a complex medical history that warrants more careful medication selection
Consider both if you:
The ideal approach for many patients combines Found's medication matching with Noom's behavioral curriculum — they address different mechanisms. Using both simultaneously is unusual but not contraindicated; the behavioral foundation from Noom enhances medication outcomes.
Related Resources
- Noom Review — full program review
- Found Weight Loss Review — full program review
- Noom vs WeightWatchers GLP-1 — behavioral programs compared
- Found vs Sequence Weight Loss — Found vs insurance navigation specialist
- Best GLP-1 Programs with Coaching — full ranking
Related Guides
Best GLP-1 Options After Foundayo Approval: Oral vs Injectable 2026
Read guide →Best Telehealth Providers for Tirzepatide 2026: Ranked by Price and Care
The best telehealth providers for tirzepatide in 2026, ranked by price, protocol, and care quality. From $278/month compounded to brand Zepbound via insurance. No provider paid for placement.
Read guide →Is Compounded Semaglutide Legal and Safe in 2026?
Is compounded semaglutide still legal? We break down the current FDA rules, 30 new warning letters, SAFE Drugs Act, Hims exiting compounded, and what this means for your prescription.
Read guide →Compounded Tirzepatide 2026: What's Happening and What Patients Should Do
Compounded tirzepatide is under active FDA enforcement as of March 2026 — supply is declining but not yet at zero. The 503B enforcement discretion ended over a year ago (March 2025); the FDA has now issued 50+ warning letters including a 30-letter batch in March 2026. Here's what patients need to know and what to do.
Read guide →